The Pulmonary Arterial Hypertension Therapeutics Market Is Expanding Due To The Development Of Novel Therapies Pulmonary Arterial Hypertension (PAH) is a rare, chronic, and progressive form of pulmonary hypertension marked by elevated pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) in blood vessels carrying blood from the right side of the heart through the… Continue reading Pulmonary Arterial Hypertension